SERIS S.R.L. (Q2036808)
Jump to navigation
Jump to search
Project Q2036808 in Italy
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | SERIS S.R.L. |
Project Q2036808 in Italy |
Statements
100,000.0 Euro
0 references
200,000.0 Euro
0 references
50.0 percent
0 references
13 April 2016
0 references
22 July 2017
0 references
31 May 2017
0 references
SERIS S.R.L.
0 references
Q282869 (Deleted Item)
0 references
44°24'26.14"N, 8°56'1.90"E
0 references
IL PROCESSO INNOVATIVO SVILUPPATO DA SERIS : LA ?BOX-INCLUSIONE? -------------------------------------------------------------------------------- SERIS HA INDIVIDUATO ED INTENDE ACQUISIRE LA LICENZA D?USO PER IL MERCATO ITALIANO DEL BREVETTO N. 102015902328523 (TO2015A000083) DEPOSITATO DALLA SOCIETA' AUSTRIACA KLAPHARM GMBH DAL TITOLO ? METODO PER LA REALIZZAZIONE DI UN SISTEMA A RILASCIO CONTROLLATO DI UNA SOSTANZA BIOLOGICAMENTE ATTIVA E SISTEMA A RILASCIO CONTROLLATO COSI' OTTENUTO?. IL BREVETTO E' RELATIVO AD UN PROCESSO DI PRODUZIONE, DENOMINATO BOX-INCLUSIONE CHE INNOVA SENSIBILMENTE LA TECNOLOGIA DI MICROINCAPSULAZIONE CLASSICA: LE SOSTANZE BIOLOGICAMENTE ATTIVE NON VENGONO SEMPLICEMENTE RIVESTITE DA UNA MATRICE SOLIDA, MA VENGONO INGLOBATE IN UNA STRUTTURA POLIGONALE TRIDIMESNIONALE AD HOC, IN CUI SONO TRATTENUTE DA DEBOLI LEGAMI ELETTROSTATICI. LA STRUTTURA E' PROGETTATA DI VOLTA IN VOLTA IN BASE ALLE CARATTERISTICHE CHIMICO-FISICHE DAL PRINCIPIO ATTIVO DA INGLOBARE E (Italian)
0 references
THE INNOVATIVE PROCESS DEVELOPED BY SEIS: LA? BOX-INCLUSION? HAVE YOU IDENTIFIED AND WILL ACQUIRE THE LICENCE D? USE FOR THE ITALIAN MARKET OF THE PATENT NO 102015902328523 (TO2015A000083) DEPOSITED BY THE AUSTRIAN COMPANY KLAPHARM GMBH? METHOD FOR THE ESTABLISHMENT OF A CONTROLLED RELEASE SYSTEM OF A BIOLOGICALLY ACTIVE SUBSTANCE AND A CONTROLLED RELEASE SYSTEM OBTAINED? THE PATENT RELATES TO A PRODUCTION PROCESS, CALLED BOX-INCLUSION, WHICH INNOVA SIGNIFICANTLY REFERS TO CLASSICAL MICRO-ENCAPSULATION TECHNOLOGY: BIOLOGICALLY ACTIVE SUBSTANCES ARE NOT SIMPLY COATED WITH A SOLID MATRIX BUT ARE EMBEDDED IN A DEDICATED POLYGONAL TRIPARTITE STRUCTURE, IN WHICH THERE ARE WEAK ELECTROSTATIC BONDS. THE STRUCTURE IS DESIGNED IN EACH CASE ON THE BASIS OF THE CHEMICAL AND PHYSICAL CHARACTERISTICS OF THE ACTIVE SUBSTANCE TO BE INCORPORATED AND (English)
0 references
LE PROCESSUS INNOVANT DÉVELOPPÉ PAR SERIS: L’INCLUSION DE LA BOÎTE? — SERIS A-T-IL IDENTIFIÉ ET ENTEND ACQUÉRIR LA LICENCE D’UTILISATION POUR LE MARCHÉ ITALIEN DU BREVET NO 102015902328523 (TO2015A000083) DÉPOSÉE PAR LA SOCIÉTÉ AUTRICHIENNE KLAPHARM GMBH? MÉTHODE DE MISE EN ŒUVRE D’UN SYSTÈME DE LIBÉRATION CONTRÔLÉE D’UNE SUBSTANCE BIOLOGIQUEMENT ACTIVE ET D’UN SYSTÈME DE LIBÉRATION CONTRÔLÉE AINSI OBTENU? LE BREVET EST LIÉ À UN PROCESSUS DE PRODUCTION, APPELÉ «BOÎTE-INCLUSION» QUI INNOVE DE MANIÈRE SIGNIFICATIVE LA TECHNOLOGIE CLASSIQUE DE MICROENCAPSULATION: LES SUBSTANCES BIOLOGIQUEMENT ACTIVES NE SONT PAS SIMPLEMENT RECOUVERTES D’UNE MATRICE SOLIDE, MAIS SONT INCORPORÉES DANS UNE STRUCTURE POLYGONALE TRIDIMESNIONAL AD HOC, DANS LAQUELLE ELLES SONT MAINTENUES PAR DE FAIBLES LIAISONS ÉLECTROSTATIQUES. LA STRUCTURE EST CONÇUE DE TEMPS À AUTRE EN FONCTION DES CARACTÉRISTIQUES CHIMIQUES ET PHYSIQUES DE LA SUBSTANCE ACTIVE À INCORPORER ET (French)
16 December 2021
0 references
Identifiers
G33G16000840007
0 references